Microcirculation: Nexus of comorbidities in diabetes

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 2, 2007, Pages

  Temm, Constance ^a   Dominguez, Jesus H ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Capillary permeability; Diabetic nephropathies

Indexed keywords

SERUM ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOFLUORESCENCE; IN VIVO STUDY; INTERSTITIAL NEPHRITIS; KIDNEY TUBULE; KIDNEY TUBULE DISORDER; MALE; METABOLIC SYNDROME X; MICROCIRCULATION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; RAT;

EID: 34548395147     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00503.2006     Document Type: Article

References (38)

1. Bohle A, Mackensen-Haen S, Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19: 191-195, 1996.
2. Chakir M, Plante GE. Endothelial dysfunction in diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids 54: 45-51, 1996.
3. Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 31: 1491-1497, 2000.
4. Cohen MP, Sharma K, Jin Y, Hud E, Wu VY, Tomaszewski J, Ziyadeh FN. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. J Clin Invest 95: 2338-2345, 1995.
5. Dawson TH. Modeling of vascular networks. J Exp Biol 208: 1687-1694, 2005.
6. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 32: 219-226, 1989.
7. Dominguez JH, Wu P, Hawes JW, Deeg M, Walsh J, Packer SC, Nagase M, Temm C, Goss E, Peterson R. Renal injury: similarities and differences in male and female rats with the metabolic syndrome. Kidney Int 69: 1969-1976, 2006.
8. Dominguez JH, Tang N, Xu W, Evan AP, Siakotos AN, Agarwal R, Walsh J, Deeg M, Pratt JH, March KL, Monnier VM, Weiss MF, Baynes JW, Peterson R. Studies of renal injury III: lipid-induced nephropathy in type II diabetes. Kidney Int 57: 92-104, 2000.
9. Dunn KW, Sandoval RM, Kelly KJ, Dagher PC, Tanner GA, Atkinson SJ, Bacallao RL, Molitoris BA. Functional studies of the kidney of living animals using multicolor two-photon microscopy. Am J Physiol Cell Physiol 283: C905-C916, 2002.
10. Evans RG, Eppel GA, Anderson WP, Denton KM. Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 22: 1439-1451, 2004.
11. Fine LG, Orphanides C, Norman JT. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int 65: S74-S78, 1998.
12. Gassler N, Elger M, Kränzlin B, Kriz W, Gretz N. Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat. Kidney Int 60: 106-116, 2001.
13. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56: 1627-1637, 1999.
14. Goligorsky MS, Chen J, Brodsky S Endothelial cell dysfunction leading to diabetic nephropathy. Focus on nitric oxide. Hypertension 37: 744-748, 2001.
15. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981.
16. Hulthen UL, Rumble J, Cooper ME, Johnston CI. Vascular albumin permeability and hypertrophy in a rat model combining streptozotoc-ininduced diabetes and genetic hypertension. J Hypertens 13: 529-533, 1995.
17. Ido Y, Chang KC, Lejeune WS, Bjercke RJ, Reiser KM, Williamson JR, Tilton RG. Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C. Microcirculation 8: 251-263, 2001.
18. Kamijo H, Higuchi M, Hora K. Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. Nephron Physiol 104: 12-22, 2006.
19. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13: 806-816, 2002.
20. Kriz W, Hartmann I, Hosser H, Hahnel B, Kranzlin B, Provoost A, Gretz N.Tracer studies in the rat demonstrate misdirected filtration and peritubular filtrate spreading in with segmental glomerulosclerosis. J Am Soc Nephrol 12: 496-506, 2001.
21. Lawson SR, Gabra BH, Nantel F, Battistini B, Sirois P. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic pro-file of major key organs. Eur J Pharmacol 514: 69-78, 2005.
22. Liao L, Aw TY, Kvietys PR, Granger DN. Oxidized LDL-induced microvascular dysfunction. Dependence on oxidation procedure. Arterioscler Thromb Vasc Biol 15: 2305-2311, 1995.
23. Matsumoto M, Tanaka T, Yamamoto T, Noiri E, Miyata T, Inagi R, Fujita T, Nangaku M. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 15: 1574-1581, 2004.
24. Molitoris BA, Sandoval RM. Intravital multiphoton microscopy of dynamic renal processes. Am J Physiol Renal Physiol 288: F1084-F1089, 2005.
25. Moore TC, Moore JE, Kaji Y, Frizzell N, Usui T, Poulaki V, Campbell IL, Stitt AW, Gardiner TA, Archer DB, Adamis AP. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Vis Sci 44: 4457-4464, 2003.
26. Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 55: 2510-2522, 2006.
27. Parving Nielsen FS Bang LE Smidt UM HH, Svendsen TL, Chen JW, Gall MA, Rossing P. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 39: 1590-1597, 1996.
28. Pinter GG, Atkins JL. Role of postglomerular microvessels in pathophysiology of diabetic nephropathy: assessment and hypothesis. Diabetes 40: 791-795, 1991.
29. Rangaswamy S, Penn MS, Saidel GM, Chisolm GM. Exogenous oxidized low-density lipoprotein injures and alters the barrier function of endothelium in rats in vivo. Circ Res 80: 37-44, 1997.
30. Rota R, Chiavaroli C, Garay RP, Hannaert P. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. Eur J Pharmacol 495: 217-224, 2004.
31. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Grone HJ, Nelson PJ, Schlondorff D, Cohen CD, Kretzler M, and for the European Renal cDNA Bank (ERCB) Consortium. Modular activation of nuclear factor-κb transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003, 2006.
32. Silveira AM, Sjoberg S, Blomback M, Ostman J. von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy. J Diabetes Complications 6: 89-95, 1992.
33. Stitt AW, Bhaduri T, McMullen CB, Gardiner TA, Archer DB. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol Cell Biol Res Commun 3: 380-388, 2000.
34. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 9: 231-242, 1998.
35. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 276: 122-126, 1997.
36. Yamaji T, Fukuhara T, Kinoshita M. Increased capillary permeability to albumin in diabetic rat myocardium. Circ Res 72: 947-957, 1993.
37. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995.
38. Zatz R, Meyer TW, Rennke HG, Brenner BM. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963-5967, 1985.